1. thegoldbug
2. ladygodiva9293
3. mponesto
4. renysion
5. 49bjoe
1.davsdu94 02/14/2018
up 11.02%.
2.thegoldbug 02/26/2018
Another biotech winner so far in 2018, up 50% so far.
3.dddimensions 04/25/2018
New Oncology Clinical Collaboration between Nektar and Takeda to Evaluate Combination of NKTR-214, a CD122-biased Agonist, and TAK-659, a Dual SYK and FLT-3 Inhibitor, in Liquid and Solid Tumors
4.49bjoe 04/11/2018
Company has initiated dosing patients in the Phase 1/2 REVEAL clinical study evaluating the efficacy and saf…
5.einstein4539 06/07/2018
Nektar Therapeutics (NKTR): One Bull Is Still 'Impressed' Despite This Stock's Worst Plunge on Record
6.nomercjr 05/14/2018
Canaccord Genuity sets PT at $94
7.ladygodiva9293 06/04/2018
H.C. Wainwright Slashes Price Target on Nektar Therapeutics (NKTR), Says 'Optimism Has Been Eroded'
8.ladygodiva9293 04/11/2018
News!!!!!
9.thegoldbug 04/16/2018
Intriguing news.
10.49bjoe 04/13/2018
Piper Jaffray resumes coverage as an overweight, $125PT
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW